Logo image of PYCR

PAYCOR HCM INC (PYCR) Stock Fundamental Analysis

NASDAQ:PYCR - US70435P1021 - Common Stock

22.49 USD
+0.04 (+0.18%)
Last: 4/11/2025, 8:18:17 PM
22.49 USD
0 (0%)
After Hours: 4/11/2025, 8:18:17 PM
Fundamental Rating

3

Overall PYCR gets a fundamental rating of 3 out of 10. We evaluated PYCR against 82 industry peers in the Professional Services industry. While PYCR seems to be doing ok healthwise, there are quite some concerns on its profitability. PYCR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year PYCR was profitable.
In the past year PYCR had a positive cash flow from operations.
In the past 5 years PYCR always reported negative net income.
Each year in the past 5 years PYCR had a positive operating cash flow.
PYCR Yearly Net Income VS EBIT VS OCF VS FCFPYCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

The Return On Assets of PYCR (-0.76%) is worse than 68.67% of its industry peers.
PYCR's Return On Equity of -1.64% is on the low side compared to the rest of the industry. PYCR is outperformed by 68.67% of its industry peers.
Industry RankSector Rank
ROA -0.76%
ROE -1.64%
ROIC N/A
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
PYCR Yearly ROA, ROE, ROICPYCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -2 -4 -6 -8 -10

1.3 Margins

PYCR's Gross Margin of 65.97% is fine compared to the rest of the industry. PYCR outperforms 77.11% of its industry peers.
In the last couple of years the Gross Margin of PYCR has remained more or less at the same level.
PYCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
PYCR Yearly Profit, Operating, Gross MarginsPYCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

PYCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
PYCR has more shares outstanding than it did 1 year ago.
PYCR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PYCR is higher compared to a year ago.
PYCR Yearly Shares OutstandingPYCR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PYCR Yearly Total Debt VS Total AssetsPYCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.64, we must say that PYCR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.64, PYCR is doing worse than 63.86% of the companies in the same industry.
There is no outstanding debt for PYCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.64
ROIC/WACCN/A
WACC8.98%
PYCR Yearly LT Debt VS Equity VS FCFPYCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.12 indicates that PYCR should not have too much problems paying its short term obligations.
The Current ratio of PYCR (1.12) is comparable to the rest of the industry.
PYCR has a Quick Ratio of 1.12. This is a normal value and indicates that PYCR is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.12, PYCR perfoms like the industry average, outperforming 43.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
PYCR Yearly Current Assets VS Current LiabilitesPYCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.73% over the past year.
The Revenue has grown by 15.73% in the past year. This is quite good.
Measured over the past years, PYCR shows a quite strong growth in Revenue. The Revenue has been growing by 17.57% on average per year.
EPS 1Y (TTM)27.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.09%
Revenue 1Y (TTM)15.73%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%13.1%

3.2 Future

PYCR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.73% yearly.
PYCR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.08% yearly.
EPS Next Y18.26%
EPS Next 2Y14.99%
EPS Next 3Y16.5%
EPS Next 5Y21.73%
Revenue Next Year12.65%
Revenue Next 2Y12.05%
Revenue Next 3Y12.26%
Revenue Next 5Y12.08%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PYCR Yearly Revenue VS EstimatesPYCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
PYCR Yearly EPS VS EstimatesPYCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.5 1 1.5 2

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 40.16, the valuation of PYCR can be described as expensive.
Based on the Price/Earnings ratio, PYCR is valued a bit more expensive than 72.29% of the companies in the same industry.
PYCR is valuated rather expensively when we compare the Price/Earnings ratio to 27.44, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 34.02, PYCR can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, PYCR is valued a bit more expensive than the industry average as 60.24% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.87. PYCR is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 40.16
Fwd PE 34.02
PYCR Price Earnings VS Forward Price EarningsPYCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PYCR indicates a slightly more expensive valuation: PYCR is more expensive than 71.08% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PYCR is valued a bit more expensive than the industry average as 65.06% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 71.33
EV/EBITDA 34.15
PYCR Per share dataPYCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PYCR does not grow enough to justify the current Price/Earnings ratio.
PYCR's earnings are expected to grow with 16.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.2
PEG (5Y)N/A
EPS Next 2Y14.99%
EPS Next 3Y16.5%

0

5. Dividend

5.1 Amount

PYCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PAYCOR HCM INC

NASDAQ:PYCR (4/11/2025, 8:18:17 PM)

After market: 22.49 0 (0%)

22.49

+0.04 (+0.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners42.91%
Inst Owner Change-96.73%
Ins Owners1.17%
Ins Owner Change-18441.1%
Market Cap4.09B
Analysts55.24
Price Target22.74 (1.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.63%
Min EPS beat(2)20.66%
Max EPS beat(2)28.59%
EPS beat(4)4
Avg EPS beat(4)17.12%
Min EPS beat(4)3.43%
Max EPS beat(4)28.59%
EPS beat(8)8
Avg EPS beat(8)25.77%
EPS beat(12)12
Avg EPS beat(12)33.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)1.24%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.24%
Revenue beat(8)6
Avg Revenue beat(8)0.4%
Revenue beat(12)10
Avg Revenue beat(12)1.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.07%
EPS NY rev (1m)-1.19%
EPS NY rev (3m)3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 40.16
Fwd PE 34.02
P/S 5.84
P/FCF 71.33
P/OCF 34.44
P/B 3.12
P/tB 12.25
EV/EBITDA 34.15
EPS(TTM)0.56
EY2.49%
EPS(NY)0.66
Fwd EY2.94%
FCF(TTM)0.32
FCFY1.4%
OCF(TTM)0.65
OCFY2.9%
SpS3.85
BVpS7.2
TBVpS1.84
PEG (NY)2.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.76%
ROE -1.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.97%
FCFM 8.19%
ROA(3y)-3.25%
ROA(5y)-3.81%
ROE(3y)-7.07%
ROE(5y)-8.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.45%
GM growth 5Y1.09%
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 47.16%
Cap/Sales 8.77%
Interest Coverage N/A
Cash Conversion 102.02%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 1.64
F-Score6
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)42.74%
Cap/Depr(5y)34.82%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.09%
EPS Next Y18.26%
EPS Next 2Y14.99%
EPS Next 3Y16.5%
EPS Next 5Y21.73%
Revenue 1Y (TTM)15.73%
Revenue growth 3Y22.9%
Revenue growth 5Y17.57%
Sales Q2Q%13.1%
Revenue Next Year12.65%
Revenue Next 2Y12.05%
Revenue Next 3Y12.26%
Revenue Next 5Y12.08%
EBIT growth 1Y83.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.22%
EBIT Next 3Y44.32%
EBIT Next 5Y41.74%
FCF growth 1Y324.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y383.14%
OCF growth 3Y102.92%
OCF growth 5YN/A